Last Updated:
Name Designation Appointment Date Status
Anjan Kumar

Appointed as Additional Director since April 2020

Additional Director 07-Apr-2020 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Jitendra Kumar

Appointed as Director since March 2020

Director 04-Mar-2020 Current
Bhadradri Ayush Reddy

Appointed as Additional Director since March 2020

Additional Director 27-Mar-2020 Current

People Timeline

Explore the timeline of key personnel in City Medi-Clinic Pharmaceuticals Limited's leadership journey.

Loading...
Contact Details
  • Address B-22, Somdutt Chamber-2 Bhikaji Cama Place, Delhi Delhi, 110066, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact City Medi-Clinic Pharmaceuticals Limited?
You can contact City Medi-Clinic Pharmaceuticals Limited through their registered address at B-22, Somdutt Chamber-2 Bhikaji Cama Place, Delhi Delhi, 110066, India, or via their website at medi-clinic.in. Social media links are also provided where applicable.
Who are the current directors of City Medi-Clinic Pharmaceuticals Limited?
The current directors of City Medi-Clinic Pharmaceuticals Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • JITENDRA KUMAR
  • ANJAN KUMAR
  • BHADRADRI AYUSH REDDY
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available